Variables | Group | Before intervention | After intervention | P-value** | Mean changes# | p-value |
---|---|---|---|---|---|---|
WBC (µL) | Saffron | 13731.06 ± 3718.4 | 9554.71 ± 2961.91 | <0.001 | -4176.34 ± 4063.01 | <0.001 |
Placebo | 13499.43 ± 4790.74 | 13,561 ± 3316.32 | 0.92 | 61.57 ± 4118.97 | ||
P-value | 0.79 | <0.001 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.05 (-0.36, 0.47) | -1.27 (-1.69, -0.86) |  |  | ||
Neutrophils (%) | Saffron | 74.31 ± 9.59 | 71.83 ± 15.22 | 0.34 | -2.47 ± 17.37 | 0.48 |
Placebo | 77.07 ± 8.43 | 74.13 ± 7.84 | 0.05 | -2.93 ± 9.95 | ||
P-value | 0.15 | 0.37 | Â | Â | ||
Cohen’s d effect size (95% CI) | -0.31 (-0.72, 0.11) | -0.19 (-0.61, 0.23) |  |  | ||
Lymphocyte (%) | Saffron | 17.19 ± 7.52 | 17.58.5.37 | 0.60 | 0.39 ± 5.09 | 0.21 |
Placebo | 14.61 ± 5.82 | 15.33 ± 5 | 0.46 | 0.71 ± 6.46 | ||
P-value | 0.07 | 0.04 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.38 (-0.04, 0.8) | 0.43 (0.01, 0.85) |  |  | ||
RBC (µL) | Saffron | 3.83 ± 0.61 | 3.75 ± 0.45 | 0.32 | -0.080.54 | 0.18 |
Placebo | 3.58 ± 0.34 | 3.54 ± 0.35 | 0.49 | -0.03 ± 0.36 | ||
P-value | 0.02 | 0.02 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.51 (0.09, 0.93) | 0.52 (0.1, 0.94) |  |  | ||
Hb (g/dL) | Saffron | 10.36 ± 1.49 | 10.24.1.58 | 0.62 | -0.11 ± 1.55 | 0.19 |
Placebo | 10.16 ± 1.42 | 9.81 ± 1.18 | 0.10 | -0.34 ± 1.38 | ||
P-value | 0.50 | 0.14 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.14 (-0.28, 0.56) | 0.31 (-0.11, 0.73) |  |  | ||
Hct (%) | Saffron | 31.44 ± 4.93 | 32.05 ± 4.87 | 0.37 | 0.60 ± 4.54 | 0.06 |
Placebo | 30.79 ± 4.57 | 30.39 ± 2.66 | 0.56 | -0.39 ± 4.55 | ||
P-value | 0.51 | 0.04 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.14 (-0.28, 0.56) | 0.42 (0.00, 0.84) |  |  | ||
MCV (fl.) | Saffron | 84.48 ± 6.47 | 85.15 ± 5.74 | 0.25 | 0.66 ± 3.84 | 0.58 |
Placebo | 85.06 ± 5.30 | 85.90 ± 4.39 | 0.10 | 0.84 ± 3.44 | ||
P-value | 0.64 | 0.48 | Â | Â | ||
Cohen’s d effect size (95% CI) | -0.1 (-0.52, 0.32) | -0.15 (-0.57, 0.27) |  |  | ||
MCH (pg) | Saffron | 27.10 ± 2.65 | 26.97 ± 1.97 | 0.54 | -0.12 ± 1.43 | 0.54 |
Placebo | 27.01 ± 1.77 | 27.03 ± 1.65 | 0.86 | 0.02 ± 0.90 | ||
P-value | 0.86 | 0.18 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.04 (-0.38, 0.46) | -0.03 (-0.45, 0.39) |  |  | ||
MCHC (g/dl) | Saffron | 32.10 ± 1.81 | 31.66 ± 1.15 | 0.06 | -0.43 ± 1.55 | 0.28 |
Placebo | 31.67 ± 1.14 | 31.80 ± 1.42 | 0.60 | 0.12 ± 1.60 | ||
P-value | 0.18 | 0.61 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.28 (-0.13, 0.70) | -0.11 (-0.53, 0.31) |  |  | ||
PLT (µL) | Saffron | 278990.79 ± 130107.67 | 308031.36 ± 78889.79 | 0.11 | 29040.56 ± 120466.12 | 0.2 |
Placebo | 243621.4 ± 112479.34 | 318532.10 ± 108062.43 | <0.001 | 74910.70 ± 108276.04 | ||
P-value | 0.17 | 0.60 | Â | Â | ||
Cohen’s d effect size (95% CI) | 0.29 (-0.13, 0.71) | -0.11 (-0.53, 0.31) |  |  |